MILAN--(BUSINESS WIRE)--Sorin Group, (MIL:SRN) (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today that it has concluded a full and final settlement of the United States Department of Justice investigation into sales and marketing practices of its subsidiary Ela Medical, Inc. and of former independent sales representatives. Tentative settlement had been previously announced by the Group on March 12th, 2010.
